We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

30 hedge funds and large institutions have $1.78M invested in Tiziana Life Sciences in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

53% more capital invested

Capital invested by funds: $1.16M → $1.78M (+$620K)

15% more funds holding

Funds holding: 2630 (+4)

0.98% more ownership

Funds ownership: 0.9%1.88% (+0.98%)

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
2
Reduced
7
Closed
7
Calls
$18K
Puts
Net Calls
+$18K
Net Calls Change
+$17K

TLSA Hedge Fund Activity: Q3 2024 in Review

30 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2024, worth a combined $1.78M — up 53% from $1.16M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TLSA positions and 7 closed out — a net gain of 4 holders — while 2 added to existing stakes and 7 trimmed.

The largest buyer was Sanctuary Advisors, opening a new position worth an estimated $917K. The largest seller was AlphaMark Advisors, exiting entirely with an estimated $309K sold.

  • 30 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2024, up from 26 in Q2 2024.
  • Funds reported $1.78M of Tiziana Life Sciences stock for Q3 2024, up 53% quarter-over-quarter.
  • 11 funds opened new Tiziana Life Sciences positions in Q3 2024 and 7 closed out, a net change of +4 holders.
  • The largest Tiziana Life Sciences buyer in Q3 2024 was Sanctuary Advisors, an estimated $917K added.
  • The largest Tiziana Life Sciences seller in Q3 2024 was AlphaMark Advisors, an estimated $309K sold.

Based on aggregated 13F filings for Q3 2024.